Presentation is loading. Please wait.

Presentation is loading. Please wait.

Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L

Published byΦυλλίδος Καραμήτσος Modified over 6 years ago

Similar presentations

Presentation on theme: "Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L"— Presentation transcript:

1 Factors predicting poor survival after resection of stage IA non–small cell lung cancer 
Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L. Colson, MD, PhD, Philip A. Linden, MD, Michael T. Jaklitsch, MD, Stuart R. Lipsitz, ScD, David J. Sugarbaker, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 134, Issue 4, Pages (October 2007) DOI: /j.jtcvs Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

2 Figure 1 A, Kaplan–Meier survival estimates comparing patients having tumors 0.1 to 2.0 cm with patients having tumors 2.1 to 3.0 cm. B, Kaplan–Meier survival estimates comparing women with men. C, Kaplan–Meier survival estimates comparing patients younger than 67 years old with patients 67 years or older. D, Kaplan–Meier survival estimates comparing patients undergoing lobectomy with patients undergoing sublobar resection. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

Download ppt "Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L"

Similar presentations

Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT)  Neal E. Dunlap,

Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT)  Neal E. Dunlap,
Stephen R. Broderick, MD, MPHS 

Stephen R. Broderick, MD, MPHS 
Tumor angiogenesis in predicting the survival of patients with stage I lung cancer  Baris Medetoglu, MD, Mehmet Zeki Gunluoglu, MD, Adalet Demir, MD, Huseyin.

Tumor angiogenesis in predicting the survival of patients with stage I lung cancer  Baris Medetoglu, MD, Mehmet Zeki Gunluoglu, MD, Adalet Demir, MD, Huseyin.
The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.

The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.
Characteristics and outcomes of secondary nodules identified on initial computed tomography scan for patients undergoing resection for primary non–small.

Characteristics and outcomes of secondary nodules identified on initial computed tomography scan for patients undergoing resection for primary non–small.
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Relationship between margin distance and local recurrence among patients undergoing wedge resection for small (≤2 cm) non–small cell lung cancer  Kamran.

Relationship between margin distance and local recurrence among patients undergoing wedge resection for small (≤2 cm) non–small cell lung cancer  Kamran.
One in every 14 patients with early-stage lung cancer is not being treated!  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular Surgery 

One in every 14 patients with early-stage lung cancer is not being treated!  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular Surgery 
Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer  Sai-Hong Ignatius Ou, MD, PhD, Jason.

Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer  Sai-Hong Ignatius Ou, MD, PhD, Jason.
It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible  Alessandro Brunelli,

It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible  Alessandro Brunelli,
Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection  Morihito Okada,

Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection  Morihito Okada,
Prognostic significance of histologic differentiation, carcinoembryonic antigen value, and lymphovascular invasion in stage I non–small cell lung cancer 

Prognostic significance of histologic differentiation, carcinoembryonic antigen value, and lymphovascular invasion in stage I non–small cell lung cancer 
Paul J. Scheel, BS, Traves D. Crabtree, MD, Jennifer M

Paul J. Scheel, BS, Traves D. Crabtree, MD, Jennifer M
Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system  Shamus R.

Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system  Shamus R.
Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules  Nasser K. Altorki, MD, Rowena Yip, MPH, Takaomi Hanaoka,

Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules  Nasser K. Altorki, MD, Rowena Yip, MPH, Takaomi Hanaoka,
Lobectomy with pulmonary artery resection: Morbidity, mortality, and long-term survival  Marco Alifano, MD, Giacomo Cusumano, MD, Salvatore Strano, MD,

Lobectomy with pulmonary artery resection: Morbidity, mortality, and long-term survival  Marco Alifano, MD, Giacomo Cusumano, MD, Salvatore Strano, MD,
Radical sublobar resection for small-sized non–small cell lung cancer: A multicenter study  Morihito Okada, MD, PhD, Teruaki Koike, MD, PhD, Masahiko.

Radical sublobar resection for small-sized non–small cell lung cancer: A multicenter study  Morihito Okada, MD, PhD, Teruaki Koike, MD, PhD, Masahiko.
Philip A. Linden, MD, Richard J. Gilbert, MD, Beow Y

Philip A. Linden, MD, Richard J. Gilbert, MD, Beow Y
Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer  Hong.

Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer  Hong.
John M. Varlotto, MD, Abram Recht, MD, John C. Flickinger, MD, Laura N

John M. Varlotto, MD, Abram Recht, MD, John C. Flickinger, MD, Laura N

Similar presentations

Ads by Google